QUINTESCIENCE Trademark

Trademark Overview

On Monday, July 22, 2024, a trademark application was filed for QUINTESCIENCE with the United States Patent and Trademark Office. The USPTO has given the QUINTESCIENCE trademark a serial number of 98659719. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, February 3, 2025. This trademark is owned by Evolution Medical Communications, LLC. The QUINTESCIENCE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business advisory services for the healthcare industry, namely, consultancy regarding healthcare communications and lifecycle management strategies for pharmaceutical companies and medical device companies
quintescience

General Information

Serial Number98659719
Word MarkQUINTESCIENCE
Filing DateMonday, July 22, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, February 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBusiness advisory services for the healthcare industry, namely, consultancy regarding healthcare communications and lifecycle management strategies for pharmaceutical companies and medical device companies

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, July 22, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEvolution Medical Communications, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPearl River, NY 10965

Trademark Events

Event DateEvent Description
Monday, July 22, 2024NEW APPLICATION ENTERED
Wednesday, January 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 30, 2025ASSIGNED TO EXAMINER
Monday, February 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 3, 2025NON-FINAL ACTION WRITTEN
Monday, February 3, 2025NON-FINAL ACTION E-MAILED

Related Keywords

quintescience companies healthcare strategies management pharmaceutical device lifecycle medical regarding services